<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cure CMD &#187; News from Other Sources</title>
	<atom:link href="http://curecmd.org/archives/category/aggregated-news/feed" rel="self" type="application/rss+xml" />
	<link>http://curecmd.org</link>
	<description>Cure CMD provides Congenital Muscular Dystrophy resources, information, and support to families, doctors, and researchers.</description>
	<lastBuildDate>Tue, 27 Jul 2010 08:00:00 +0000</lastBuildDate>
	
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>New Approach Which Can Help To Predict Neurodegenerative Diseases</title>
		<link>http://mnt.to/f/3GBH</link>
		<comments>http://mnt.to/f/3GBH#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3GBH</guid>
		<description><![CDATA[New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America...]]></description>
			<content:encoded><![CDATA[New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America...]]></content:encoded>
			<wfw:commentRss>http://mnt.to/f/3GBH/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Probes Oxidative Stress in People with ALS</title>
		<link>http://alsn.mda.org/news/study-probe-oxidative-stress-people-als</link>
		<comments>http://alsn.mda.org/news/study-probe-oxidative-stress-people-als#comments</comments>
		<pubDate>Tue, 27 Jul 2010 04:15:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">tag:www.mda.org://b9b61cd2f6fc03051f15da2345f754a5</guid>
		<description><![CDATA[Participants are being sought for a 12-center study that will follow people with ALS over time to examine relationships between the disease and oxidative stress.]]></description>
			<content:encoded><![CDATA[Participants are being sought for a 12-center study that will follow people with ALS over time to examine relationships between the disease and oxidative stress.]]></content:encoded>
			<wfw:commentRss>http://alsn.mda.org/news/study-probe-oxidative-stress-people-als/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8216;Power for the Journey&#8217; Gives Back to ALS Community</title>
		<link>http://alsn.mda.org/news/%E2%80%98power-journey%E2%80%99-gives-back-als-community</link>
		<comments>http://alsn.mda.org/news/%E2%80%98power-journey%E2%80%99-gives-back-als-community#comments</comments>
		<pubDate>Sat, 24 Jul 2010 03:46:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">tag:www.mda.org://46b5149fa8ba1677b8028bd46209b0b7</guid>
		<description><![CDATA[Part support group, part fundraising effort, this group seeks to fuel ALS research while offering comfort to those who are coping with the disease.]]></description>
			<content:encoded><![CDATA[Part support group, part fundraising effort, this group seeks to fuel ALS research while offering comfort to those who are coping with the disease.]]></content:encoded>
			<wfw:commentRss>http://alsn.mda.org/news/%E2%80%98power-journey%E2%80%99-gives-back-als-community/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Utah Researchers Seek CMD Families</title>
		<link>http://quest.mda.org/news/utah-researchers-seek-cmd-families</link>
		<comments>http://quest.mda.org/news/utah-researchers-seek-cmd-families#comments</comments>
		<pubDate>Fri, 23 Jul 2010 23:44:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">tag:www.mda.org://8571719774a7605df4ed30064c5e32cc</guid>
		<description><![CDATA[Families affected by Ullrich congenital MD or Bethlem myopathy are invited to help with data collection at the University of Utah.]]></description>
			<content:encoded><![CDATA[Families affected by Ullrich congenital MD or Bethlem myopathy are invited to help with data collection at the University of Utah.]]></content:encoded>
			<wfw:commentRss>http://quest.mda.org/news/utah-researchers-seek-cmd-families/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nonwalkers with SMA at High Risk for Weight Gain</title>
		<link>http://quest.mda.org/news/nonwalkers-sma-high-risk-weight-gain</link>
		<comments>http://quest.mda.org/news/nonwalkers-sma-high-risk-weight-gain#comments</comments>
		<pubDate>Fri, 23 Jul 2010 03:38:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">tag:www.mda.org://bea3f2c1aa52aa2642b4acc136ec5567</guid>
		<description><![CDATA[Study finds that children and adults with SMA who can't walk but otherwise have good motor function are at risk for becoming overweight.]]></description>
			<content:encoded><![CDATA[Study finds that children and adults with SMA who can't walk but otherwise have good motor function are at risk for becoming overweight.]]></content:encoded>
			<wfw:commentRss>http://quest.mda.org/news/nonwalkers-sma-high-risk-weight-gain/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AVI BioPharma Announces Presentations On Exon Skipping Drug AVI-4658 For Treatment Of Duchenne Muscular Dystrophy</title>
		<link>http://mnt.to/f/3Ghn</link>
		<comments>http://mnt.to/f/3Ghn#comments</comments>
		<pubDate>Mon, 19 Jul 2010 10:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3Ghn</guid>
		<description><![CDATA[AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, announced upcoming presentations on AVI-4658, the Company's exon skipping therapy for the treatment of Duchenne muscular dystrophy, at the XII International Congress on Neuromuscular Diseases taking place July 17-22, 2010 in Naples, Italy...]]></description>
			<content:encoded><![CDATA[AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, announced upcoming presentations on AVI-4658, the Company's exon skipping therapy for the treatment of Duchenne muscular dystrophy, at the XII International Congress on Neuromuscular Diseases taking place July 17-22, 2010 in Naples, Italy...]]></content:encoded>
			<wfw:commentRss>http://mnt.to/f/3Ghn/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Way To Grow Adult Stem Cells In Culture May Lead To Treatment For Muscular Dystrophy</title>
		<link>http://mnt.to/f/3GbY</link>
		<comments>http://mnt.to/f/3GbY#comments</comments>
		<pubDate>Sat, 17 Jul 2010 07:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3GbY</guid>
		<description><![CDATA[Researchers at the Stanford University School of Medicine have developed a technique they believe will help scientists overcome a major hurdle to the use of adult stem cells for treating muscular dystrophy and other muscle-wasting disorders that accompany aging or disease: They've found that growing muscle stem cells on a specially developed synthetic matrix that mimics the ela...]]></description>
			<content:encoded><![CDATA[Researchers at the Stanford University School of Medicine have developed a technique they believe will help scientists overcome a major hurdle to the use of adult stem cells for treating muscular dystrophy and other muscle-wasting disorders that accompany aging or disease: They've found that growing muscle stem cells on a specially developed synthetic matrix that mimics the ela...]]></content:encoded>
			<wfw:commentRss>http://mnt.to/f/3GbY/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antisense Treatment Restores Full-Length SMN in SMA Mice</title>
		<link>http://quest.mda.org/news/antisense-treatment-restores-full-length-smn-sma-mice</link>
		<comments>http://quest.mda.org/news/antisense-treatment-restores-full-length-smn-sma-mice#comments</comments>
		<pubDate>Sat, 17 Jul 2010 02:01:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">tag:www.mda.org://b496b4922f03cd5d95a0aa0817200ef4</guid>
		<description><![CDATA[Mice with a disease resembling type 3 SMA received infusions directly into the brain of a type of molecule known as a synthetic antisense oligonucleotide.]]></description>
			<content:encoded><![CDATA[Mice with a disease resembling type 3 SMA received infusions directly into the brain of a type of molecule known as a synthetic antisense oligonucleotide.]]></content:encoded>
			<wfw:commentRss>http://quest.mda.org/news/antisense-treatment-restores-full-length-smn-sma-mice/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AVI BioPharma Opens Investigational New Drug (IND) Application For AVI-4658 In Duchenne Muscular Dystrophy</title>
		<link>http://mnt.to/f/3FQh</link>
		<comments>http://mnt.to/f/3FQh#comments</comments>
		<pubDate>Thu, 08 Jul 2010 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3FQh</guid>
		<description><![CDATA[AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced that following review by the U.S. Food and Drug Administration the Company's Investigational New Drug (IND) application for AVI-4658 is open...]]></description>
			<content:encoded><![CDATA[AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced that following review by the U.S. Food and Drug Administration the Company's Investigational New Drug (IND) application for AVI-4658 is open...]]></content:encoded>
			<wfw:commentRss>http://mnt.to/f/3FQh/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Of Mice and Men: ALS TDI Discusses ALS Research Animals</title>
		<link>http://alsn.mda.org/news/mice-and-men-als-tdi-discusses-als-research-animals</link>
		<comments>http://alsn.mda.org/news/mice-and-men-als-tdi-discusses-als-research-animals#comments</comments>
		<pubDate>Wed, 07 Jul 2010 03:29:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false">tag:www.mda.org://2f7c0c8faf9be23d2f42d7836e24c476</guid>
		<description><![CDATA[Animal models play a key role in ALS research, but their usage can be tricky, said ALS TDI in its recent public webinar.]]></description>
			<content:encoded><![CDATA[Animal models play a key role in ALS research, but their usage can be tricky, said ALS TDI in its recent public webinar.]]></content:encoded>
			<wfw:commentRss>http://alsn.mda.org/news/mice-and-men-als-tdi-discusses-als-research-animals/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
